Aurinia Pharmaceuticals Inc (AUPH): Next-Year EPS Estimate 31.02%
As of 2026-05-07, Aurinia Pharmaceuticals Inc (AUPH) has a next-year EPS growth estimate of 31.02%.
On 2026-05-07, analyst consensus for AUPH's next-year EPS growth shifted from 30.12% to 31.02% — a positive change of 0.90 percentage points. Current-year growth is projected at -60.55%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 31.02%
- EPS growth this year
- -60.55%
- EPS next quarter (est)
- $0.21
- Last price
- $14.91
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 31.02% | -60.55% | $0.21 | $14.91 |
| 2026-05-06 | 30.12% | -60.71% | $0.20 | $16.25 |
| 2026-05-05 | 30.12% | -60.71% | $0.20 | $16.04 |
| 2026-05-04 | 30.12% | -60.71% | $0.20 | $15.77 |
| 2026-05-03 | 30.12% | -60.71% | $0.20 | $15.35 |
| 2026-04-30 | 30.12% | -60.71% | $0.20 | $15.39 |
| 2026-04-29 | 30.12% | -60.71% | $0.20 | $15.28 |
| 2026-04-28 | 30.12% | -60.71% | $0.20 | $16.04 |
| 2026-04-27 | 30.12% | -60.71% | $0.20 | $16.37 |
| 2026-04-26 | 30.12% | -60.71% | $0.20 | $15.98 |
| 2026-04-24 | 30.12% | -60.71% | $0.20 | $15.98 |
| 2026-04-23 | 30.12% | -60.71% | $0.20 | $16.14 |
| 2026-04-22 | 30.12% | -60.71% | $0.20 | $16.42 |
| 2026-04-21 | 30.12% | -60.71% | $0.20 | $15.82 |
| 2026-04-20 | 30.12% | -60.71% | $0.20 | $15.96 |
| 2026-04-19 | 30.12% | -60.71% | $0.20 | $16.05 |
| 2026-04-16 | 30.12% | -60.71% | $0.20 | $15.83 |
| 2026-04-15 | 30.12% | -60.71% | $0.20 | $16.05 |
| 2026-04-14 | 30.12% | -60.71% | $0.20 | $16.07 |
| 2026-04-13 | 30.12% | -60.71% | $0.20 | $16.06 |
| 2026-04-12 | 30.12% | -60.71% | $0.20 | $15.76 |
| 2026-04-10 | 30.12% | -60.71% | $0.20 | $15.68 |
| 2026-04-09 | 30.12% | -60.71% | $0.20 | $15.96 |
| 2026-04-08 | 30.12% | N/A | $0.20 | $15.89 |
| 2026-04-07 | 30.12% | N/A | $0.20 | $15.79 |
| 2026-04-06 | 30.12% | N/A | $0.20 | $15.79 |
| 2026-04-05 | 30.12% | N/A | $0.20 | $15.61 |
| 2026-04-03 | 30.12% | N/A | $0.20 | $15.79 |
| 2026-04-02 | 30.12% | N/A | $0.20 | $15.79 |
| 2026-04-01 | 30.12% | N/A | $0.20 | $15.79 |
Recent News
- Aurinia: Q1 Earnings SnapshotAssociated Press
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Aurinia Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-05-07, Aurinia Pharmaceuticals Inc (AUPH) has a next-year EPS growth estimate of 31.02%, based on analyst consensus.
When was the latest EPS estimate revision for AUPH?▾
The most recent revision occurred on 2026-05-07, when analysts adjusted the next-year EPS growth estimate from 30.12% to 31.02%.
What sector and industry does Aurinia Pharmaceuticals Inc belong to?▾
Aurinia Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AUPH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aurinia Pharmaceuticals Inc (AUPH) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports